Pharma · Private company
Novartis
Track this companyFree. Adds Novartis to your Dealase workspace and tells you when its record changes.
Clinical trials2525 recruiting or active
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Clinical trials25
- Lymphodepletion With Low Dose Total Body Irradiation Before Standard of Care Tisagenlecleucel for the Treatment of Relapsed and Recurrent Large B-cell LymphomaPHASE1 · RECRUITING · started Dec 1, 2026ClinicalTrials.gov NCT07676877 · fetched Nov 12, 2026
- Pluvicto for the Treatment of African American Men With Metastatic Castration-Resistant Prostate CancerPHASE2 · NOT_YET_RECRUITING · started Nov 2, 2026ClinicalTrials.gov NCT07860554 · fetched Nov 12, 2026
- Overcoming Racial Disparities in Screening MammographyNA · NOT_YET_RECRUITING · started Oct 31, 2026ClinicalTrials.gov NCT07549139 · fetched Nov 12, 2026
- Mechanistic Evaluation of Atrasentan in Patients With IgA Nephropathy (IgAN)PHASE4 · NOT_YET_RECRUITING · started Sep 29, 2026ClinicalTrials.gov NCT07820995 · fetched Nov 12, 2026
- CAR-T ceLL for Eradication of Active Residual Disease in LBCL (CLEAR-1 Study)PHASE1 · RECRUITING · started Sep 15, 2026ClinicalTrials.gov NCT07443137 · fetched Nov 12, 2026
- Brain Imaging and Immune Changes During Remibrutinib Treatment in Multiple Sclerosis.RECRUITING · started Aug 15, 2026ClinicalTrials.gov NCT07758270 · fetched Nov 12, 2026
- Asciminib in HER2+ Breast Cancer Brain MetastasesPHASE1_PHASE2 · RECRUITING · started Jul 7, 2026ClinicalTrials.gov NCT07136428 · fetched Nov 12, 2026
- 24VA022; VATCH Alpelisib for TIE2/PIK3CA Pathway VAsPHASE2 · RECRUITING · started Aug 27, 2025ClinicalTrials.gov NCT07543822 · fetched Nov 12, 2026
- 24VA021; VATCH Trametinib for Ras/MAPK Pathway VAsPHASE2 · RECRUITING · started Aug 27, 2025ClinicalTrials.gov NCT07549646 · fetched Nov 12, 2026
- Comparison of 177Lu-PSMA-617 and 225Ac-PSMA-617PHASE1 · RECRUITING · started Jul 8, 2025ClinicalTrials.gov NCT07054346 · fetched Nov 12, 2026
- Low PSMA SUV Boost (LPS-Boost): Intensified 177Lu-PSMA-617 Treatment for Patients With Metastatic Castrate-Resistant Prostate Cancer With Low PSMA Expressing DiseasePHASE2 · RECRUITING · started Apr 29, 2025ClinicalTrials.gov NCT06526299 · fetched Nov 12, 2026
- LDL-C Optimization Using Inclisiran in Patients in Which Drug-Drug Interactions Limit LDL LoweringPHASE4 · RECRUITING · started Apr 2, 2025ClinicalTrials.gov NCT06865885 · fetched Nov 12, 2026
- Phase II Study of Asciminib for Second-line Treatment of Chronic Phase Chronic Myeloid LeukemiaPHASE2 · RECRUITING · started Feb 14, 2025ClinicalTrials.gov NCT06629584 · fetched Nov 12, 2026
- Vorinostat and 177Lu-PSMA-617 for the Treatment of PSMA-Low Metastatic Castration-Resistant Prostate CancerPHASE2 · RECRUITING · started Sep 18, 2024ClinicalTrials.gov NCT06145633 · fetched Nov 12, 2026
- Tulmimetostat (DZR123) in Patients With Mycosis Fungoides and Sézary SyndromePHASE1 · ACTIVE_NOT_RECRUITING · started Jan 9, 2024ClinicalTrials.gov NCT05944562 · fetched Nov 12, 2026
- Phase 1b Study of OP-1250 (Palazestrant) in Combination With Ribociclib, Alpelisib, Everolimus, or Atirmociclib in ER+, HER2- Breast CancerPHASE1 · ACTIVE_NOT_RECRUITING · started Aug 31, 2022ClinicalTrials.gov NCT05508906 · fetched Nov 12, 2026
- Pan Tumor Rollover StudyPHASE2 · RECRUITING · started Aug 9, 2019ClinicalTrials.gov NCT03899155 · fetched Nov 12, 2026
- Efficacy and Safety of Erenumab in Pediatric Participants With Episodic MigrainePHASE3 · ACTIVE_NOT_RECRUITING · started Jul 19, 2019ClinicalTrials.gov NCT03836040 · fetched Nov 12, 2026
- Ribociclib in Combination With Everolimus and Dexamethasone in Relapsed ALLPHASE1 · ACTIVE_NOT_RECRUITING · started Jan 30, 2019ClinicalTrials.gov NCT03740334 · fetched Nov 12, 2026
- Up-front CART-BCMA With or Without huCART19 in High-risk Multiple MyelomaPHASE1 · ACTIVE_NOT_RECRUITING · started May 9, 2018ClinicalTrials.gov NCT03549442 · fetched Nov 12, 2026
- A Study of Dabrafenib and/or Trametinib in Patients With Relapsed and/or Refractory Multiple MyelomaPHASE1 · ACTIVE_NOT_RECRUITING · started Jun 21, 2017ClinicalTrials.gov NCT03091257 · fetched Nov 12, 2026
- Trametinib in Combination With Paclitaxel in the Treatment of Anaplastic Thyroid CancerEARLY_PHASE1 · ACTIVE_NOT_RECRUITING · started Mar 15, 2017ClinicalTrials.gov NCT03085056 · fetched Nov 12, 2026
- TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage CancerPHASE2 · RECRUITING · started Mar 14, 2016ClinicalTrials.gov NCT02693535 · fetched Nov 12, 2026
- Sequential Two-agent Assessment in Renal Cell Carcinoma Therapy: The START TrialPHASE2 · ACTIVE_NOT_RECRUITING · started Jan 19, 2011ClinicalTrials.gov NCT01217931 · fetched Nov 12, 2026
- Letrozole and RAD001 With Advanced or Recurrent Endometrial CancerPHASE2 · ACTIVE_NOT_RECRUITING · started Apr 30, 2010ClinicalTrials.gov NCT01068249 · fetched Nov 12, 2026